Public Company News

Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting

SHANGHAI, April 1, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that results of its investigational drug candidatesDZD8586 and DZD6008, have been selected for pr...

2025-04-01 18:18 2473

Zeekr Group Announces March 2025 Delivery Update

HANGZHOU, China, April 1, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced its delivery results forMarch 2025. In March, Zeekr Group delivered a total of 40,715 veh...

2025-04-01 16:00 2424

Roborock Releases Matter Protocol Update, Leading Smart Home Integration

HONG KONG, April 1, 2025 /PRNewswire/ -- Roborock, the global leader in ultra-intelligent home robotics engineered to simplify daily life, is proud to announce an important firmware update that enhances the implementation of the Matter protocol across several of its premium robot vacuum models. ...

2025-04-01 14:05 3307

ECHO IQ SIGNS STRATEGIC PARTNERSHIP AND INTEGRATION AGREEMENTS WITH SCIMAGE AND MEDAXIOM TO EXPAND ECHOSOLV AS ACROSS 36 US CARDIOLOGY NETWORKS

* EchoSolv AS will be fully integrated into ScImage's medical workflow platform, facilitating streamlined deployment within MedAxiom's hospital and cardiology networks. * ScImage is a nationally recognised Cloud and integrated workflow management platform, with over 1,200 users, specialisin...

2025-04-01 13:39 2605

Merck Exercised the Option for the Global Rights of Abbisko Therapeutics's Pimicotinib

SHANGHAI, March 31, 2025 /PRNewswire/ -- On April 1, 2025, Beijing Time, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") announced that Merck has exercised the global commercialization option for pimicotinib (ABSK021), with an option exercise fee ofUSD85.0 million, under the licensing agr...

2025-04-01 08:48 2063

Recon Technology, Ltd Reports Financial Results for the First Six Months of Fiscal Year 2025

BEIJING, March 31, 2025 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company"), aChina-based independent solutions integrator in the oilfield service and environmental protection, electric power and coal chemical industries, today announced its financial results for the f...

2025-04-01 04:30 3383

Dogness Reports Financial Results for the Six Months Ended December 31, 2024

DONGGUAN, China and PLANO, Texas, March 31, 2025 /PRNewswire/ -- Dogness (International) Corporation ("Dogness" or the "Company") (NASDAQ: DOGZ), a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products,  today announced its financial results for...

2025-04-01 04:30 3173

Eoptolink Demonstrates 1.6T LRO Modules at OFC 2025

SAN FRANCISCO, March 31, 2025 /PRNewswire/ -- Eoptolink Technology Inc., Ltd. (SZSE: 300502), a leading innovator and provider of advanced optical transceiver solutions, is demonstrating its 1.6T LRO transceiver operating at 212Gb/s per lambda during OFC 2025. Linear Receive Optics (LRO) are o...

2025-03-31 22:00 2386

Eoptolink Unveils Industry-First 800G Optical Transceiver for Multicore Fiber at OFC 2025

SAN FRANCISCO, March 31, 2025 /PRNewswire/ -- Eoptolink Technology Inc., Ltd. (SZSE: 300502), a leading innovator and provider of advanced optical transceiver solutions, is demonstrating industry's first 800G optical transceiver supporting Multicore Fiber (MCF) at OFC 2025. The exponential gro...

2025-03-31 22:00 2051

NamiBox and Tencent Cloud Announce Strategic Partnership with Sichuan Education Press to Launch AI-Powered Writing Solution

"AI Writing Companion" Marks Industry-First Integration of AI Technology and Traditional Composition Materials Projected to Generate Over 5 million USD in Revenue in 2025 SHANGHAI, March 31, 2025 /PRNewswire/ -- Jinxin Technology Holding Company (Nasdaq: NAMI), a leading provider of AI-driven dig...

2025-03-31 21:30 3650

m-FINANCE and CBCX Markets Form Strategic Partnership to Enhance Liquidity Network

HONG KONG, March 31, 2025 /PRNewswire/ -- m-FINANCE Limited ("m-FINANCE"), a wholly owned subsidiary of mF International Limited (Nasdaq: MFI) and a provider of forex and bullion trading solutions inAsia, today announced a new strategic partnership with CBCX Markets Limited ("CBCX"), a multi-asse...

2025-03-31 21:28 3014

Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research

Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aiming to accelerate personalized cancer care SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics...

2025-03-31 21:00 2299

SunCar Technology Wins Bid to Provide Smart Car Wash Services for Agricultural Bank of China Sichuan Branch

NEW YORK, March 31, 2025 /PRNewswire/ -- SunCar Technology Group Inc. ("SunCar" or the "Company") (NASDAQ: SDA), an innovative leader in auto e-insurance and cloud-based B2B auto services inChina, today announced it has been awarded a contract to provide car wash and smart car wash concierge serv...

2025-03-31 20:45 2582

Hesai Lidar Exclusively Powers Baidu Apollo Go's Deployment of Over 1,000 L4 Autonomous Vehicles in Dubai

PALO ALTO, Calif., March 31, 2025 /PRNewswire/ -- Hesai Technology (Nasdaq: HSAI), the global leader in lidar technology for automotive mobility and robotics applications, today announced that its lidar solution will power Apollo Go's landmark expansion intoDubai, accelerating the global adoption...

2025-03-31 20:30 2658

Samsung SDI Begins Production of 46-Series Cylindrical Batteries and Initial Supply for U.S. Customer

Larger-size cylindrical batteries produced for use in micro mobility and to be expanded for electric vehicles Product portfolio diversified with 46-series addition, enabling the company to take market leadership SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Samsung SDI today announced the ...

2025-03-31 19:00 2487

Harbour BioMed Reports Full Year 2024 Financial Results

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced its ...

2025-03-31 18:13 3295

ATRenew Announces Grand Opening of Paijitang Flagship Store in Shenzhen

SHANGHAI, March 31, 2025 /PRNewswire/ -- ATRenew Inc. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven platform for pre-owned consumer electronics transactions and services inChina, today launched the grand opening of its Paijitang flagship store inShenzhen. Located in Huaq...

2025-03-31 17:00 2780

New Oriental to Report Third Quarter 2025 Financial Results on April 23, 2025

BEIJING, March 31, 2025 /PRNewswire/ -- New Oriental Education and Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services inChina, today announced that it will report its financial results for the third quarter endedFebruary 28, ...

2025-03-31 17:00 1891

Alibaba.com Records Double-Digit Order Growth in the USA During March Expo

March Expo, Alibaba.com's flagship sourcing event, saw US SME buyers leverage AI and digital sourcing to build new supplier partnerships and unlock growth opportunities  NEW YORK, March 31, 2025 /PRNewswire/ -- Alibaba.com , a leading platform for global business-to-bus...

2025-03-31 16:00 2047

Akeso's 2024 Results: Strengthening Global Competitiveness and Transforming the Treatment Landscape with Bispecific Antibodies

Key Highlights: * Global first "immuno + anti-vascular" bispecific antibody approved: ivonescimab for EGFR-TKI resistant nsq-NSCLC. Phase III HARMONi study topline data expected mid-2025 (FDA FTD). * ivonescimab outperforms pembrolizumab in Phase III study for first-line PD-L1+ NSCLC: mPFS H...

2025-03-31 02:32 3403
1 ... 9899100101102103104 ... 777

Week's Top Stories